Zydus’ New Jersey Office Clears USFDA Inspection with Nil Observations
The development comes as Zydus continues to expand its portfolio of generic medicines in the US market.
The development comes as Zydus continues to expand its portfolio of generic medicines in the US market.
Developed by Marani Health, the FDA-cleared maternal monitoring technology ‘M•care System’ is expected to be commercially available next year in the US.
New initiatives launched at Arogya Manthan 2026 include a National Healthcare Providers Registry mobile app, Secure Data Environment, and an auto-adjudication framework for AB PM-JAY claims, alongside new guidance for payers and digital health facilities.
Protect the Protectors: Doctors discuss rising violence against medical professionals, concerns around the commercialisation of healthcare, and the need for stronger security, legal and emotional support.
Temasek has joined Romsons as a long-term strategic partner through a minority investment.
Hair vaccine: Myth or future therapeutic reality? A new study explores how immune regulation, regenerative medicine and emerging technologies could shape the future of hair-loss treatment.
The new facility brings injection moulding, extrusion, stretch blow moulding and controlled cleanroom manufacturing under one platform, expanding SJML’s capabilities across precision components, medical consumables and diagnostic applications.
Cardiovascular risk can develop early and often without obvious symptoms. Doctors highlight the health checks young adults should consider to detect potential heart risks early.
High-protein diet: Are Indians blindly following the trend and missing what it means for their heart?
Roche’s Board of Directors has approved a proposal to elect former Takeda CEO Christophe Weber to the company’s Board.